Results 171 to 180 of about 30,927 (291)

Evaluation of gallbladder and biliary duct disease using microbubble contrast-enhanced ultrasound [PDF]

, 2010
Lisa Meacock, Maria E. Sellars, Paul S. Sidhu   +2 more
openalex   +1 more source

Nationwide Real‐World Usage of Blood‐Based (Liquid) Biomarker Testing in Japan

Cancer Science, EarlyView.
This database analysis explores how liquid biopsy testing is integrated into clinical practice in Japan. ABSTRACT Despite the advances in precision oncology through biomarker testing, not all patients are able to benefit from treatment decisions guided by tissue‐based testing like comprehensive genomic profiling (CGP).
Yasushi Yatabe, Ryosuke Watanabe, Yuko Kotera, Shotaro Yasuoka, Daisuke Ennishi   +4 more
wiley   +1 more source

Oral contraceptives and risk of gallbladder disease [PDF]

, 2011
Mahyar Etminan
openalex   +1 more source

lncDILC Downregulation in Liver Cancer‐Associated Fibroblasts Drives Pro‐Invasive Conversion via a miR‐6071‐ZNF395 Axis

Cancer Science, EarlyView.
We found in the present study the loss‐of‐function of a sequential inhibitory cascade of lncDILC‐miR‐6071‐ZNF395 in liver CAFs, which promoted the NF‐CAF conversion through increasing expression of pro‐invasive cytokines like IL‐6, LIF, CXCL12, and TGF‐β.
Yawen Li, Jilong Liu, Shentao Tai, Dandan Tong, Bifeng Wang, Dingbing Lu, Guoqing Shi, Xuemei Liu   +7 more
wiley   +1 more source

Sonographic Gallbladder Abnormality Is Associated with Intravenous Immunoglobulin Resistance in Kawasaki Disease [PDF]

, 2012
Chih-Jen Chen, Fu-Chen Huang, Mao‐Meng Tiao, Ying-Hsien Huang, Li-Yan Lin, Hong‐Ren Yu, Kuender D. Yang, Yi-Chuan Huang, Chih‐Cheng Chen, Wei‐Chiao Chang, Ho‐Chang Kuo   +10 more
openalex   +1 more source

Asymptomatic does not differ from symptomatic gallstone disease in gallbladder inflammation index nor in molecular abnormalities associated with gallbladder carcinoma

, 2003
Fernando Pimentel, Juan Francisco Miquel, I. Wistuba   +2 more
openalex   +1 more source

Percutaneous cholecystostomy in acute acalculous cholecystitis [PDF]

, 1989
Arbogast, Helmut, Berger, H., Pratschke, Ekkehard, Stäbler, A.   +3 more
core   +1 more source

Vendor‐Agnostic Vision Transformer‐Based Artificial Intelligence for Peroral Cholangioscopy: Diagnostic Performance in Biliary Strictures Compared With Convolutional Neural Networks and Endoscopists

Digestive Endoscopy, EarlyView.
ABSTRACT Objectives Accurate diagnosis of biliary strictures remains challenging. This study aimed to develop an artificial intelligence (AI) system for peroral cholangioscopy (POCS) using a Vision Transformer (ViT) architecture and to evaluate its performance compared to different vendor devices, conventional convolutional neural networks (CNNs), and ...
Ryosuke Sato, Kazuyuki Matsumoto, Masahiro Tomiya, Takayoshi Tanimoto, Akimitsu Ohto, Kentaro Oki, Satoshi Kajitani, Tatsuya Kikuchi, Akihiro Matsumi, Kazuya Miyamoto, Yuki Fujii, Daisuke Uchida, Koichiro Tsutsumi, Shigeru Horiguchi, Yoshiro Kawahara, Motoyuki Otsuka   +15 more
wiley   +1 more source

Weight loss interventions and obesity‐associated cancers in people with type 2 diabetes and overweight/obesity: A real‐world observational study

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To evaluate whether weight‐loss interventions are associated with obesity‐associated cancers (OAC) in individuals with overweight/obesity and type 2 diabetes (T2D). Materials and Methods This retrospective cohort study utilised the TriNetX federated research network.
Testimony Ipaye, Jonathan Goldney, Thomas J. Wilkinson, Francesco Zaccardi, Thomas Yates, Melanie J. Davies, Karen Brown, Dimitris Papamargaritis   +7 more
wiley   +1 more source

A review of multidisciplinary care in metabolic dysfunction‐associated steatohepatitis and cardiometabolic disease, with a focus on Canada

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Cardiometabolic disease (CMD) is associated with an increased risk of metabolic dysfunction‐associated steatohepatitis (MASH). Most patients develop MASH in association with type 2 diabetes and obesity. Optimal disease management requires effective multidisciplinary collaboration between primary care physicians and specialists from different ...
James Kim, Paolo Raggi, Anne‐Marie Carreau, Sean Wharton, Alice Y. Y. Cheng, Mark G. Swain   +5 more
wiley   +1 more source